4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-223966
Chief Medical Officer sold 1,564 shares at $18.36 ($28,715)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kerr Douglas · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-13 | Sale : show line 1 in the form 10b5-1 | −1,564 | $18.36 | $28,715 | 170,042 | D |
| Open-market sales · 1,564 sh · avg $18.36 · $28,715 | ||||||
Loading xslF345X06/ownership.xml…